NVAX Overview
Upcoming Projects (NVAX)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (NVAX)
-
A Second Look: Discussing Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates with a focus on the data from the recent Phase 3 Trial
Tickers: NVAX, MRNA, PFE
Executed On: Jun 20, 2025 at 09:00 AM EDT -
Discussing Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates with a focus on the data from the recent Phase 3 Trial
Tickers: NVAX, MRNA, PFE
Executed On: Jun 17, 2025 at 03:30 PM EDT -
Third View: Discussing the recent FDA approval for Novavax's Covid vaccine after six-week delay, but for a smaller population.
Ticker: NVAX
Executed On: May 23, 2025 at 10:00 AM EDT -
Second View: Discussing the recent FDA approval for Novavax's Covid vaccine after six-week delay, but for a smaller population.
Ticker: NVAX
Executed On: May 22, 2025 at 12:30 PM EDT -
Discussing the recent FDA approval for Novavax's Covid vaccine after six-week delay, but for a smaller population.
Ticker: NVAX
Executed On: May 22, 2025 at 11:00 AM EDT -
A Third Opinion: A fresh look at Novavax’s new protein-based Covid vaccine potential use in people ages 12 and up
Ticker: NVAX
Executed On: Apr 24, 2025 at 03:00 PM EDT -
A Second Opinion: A fresh look at Novavax’s new protein-based Covid vaccine potential use in people ages 12 and up
Ticker: NVAX
Executed On: Apr 24, 2025 at 11:30 AM EDT -
A fresh look at Novavax’s new protein-based Covid vaccine potential use in people ages 12 and up
Ticker: NVAX
Executed On: Apr 23, 2025 at 02:00 PM EDT -
A Third View: Taking a look at the FDA authorization of Novavax’s new protein-based Covid vaccine for emergency use in people ages 12 and up
Ticker: NVAX
Executed On: Sep 17, 2024 at 01:00 PM EDT -
A Second View: Taking a look at the FDA authorization of Novavax’s new protein-based Covid vaccine for emergency use in people ages 12 and up
Ticker: NVAX
Executed On: Sep 13, 2024 at 09:00 AM EDT -
Taking a look at the FDA authorization of Novavax’s new protein-based Covid vaccine for emergency use in people ages 12 and up
Ticker: NVAX
Executed On: Sep 12, 2024 at 12:00 PM EDT -
A loot at the current treatment landscape and how Novavax COVID-19 Vaccine fits in to protect against new SARS-CoV-2 omicron variants
Ticker: NVAX
Executed On: Oct 20, 2023 at 11:00 AM EDT
Expired Projects (NVAX)
-
Discussing the implications of recent changes to the Advisory Committee on Immunization Practices (ACIP) and its impacts on vaccine makers, their strategies, and vaccine availability.
Tickers: MRNA, NVAX
Scheduled For: Jun 20, 2025 at 11:00 AM EDT
Upcoming & Overdue Catalysts (NVAX)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (NVAX)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
